RT Journal Article
SR Electronic
T1 Viral infection and transmission in a large, well-traced outbreak caused by the SARS-CoV-2 Delta variant
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.07.07.21260122
DO 10.1101/2021.07.07.21260122
A1 Baisheng Li
A1 Aiping Deng
A1 Kuibiao Li
A1 Yao Hu
A1 Zhencui Li
A1 Qianling Xiong
A1 Zhe Liu
A1 Qianfang Guo
A1 Lirong Zou
A1 Huan Zhang
A1 Meng Zhang
A1 Fangzhu Ouyang
A1 Juan Su
A1 Wenzhe Su
A1 Jing Xu
A1 Huifang Lin
A1 Jing Sun
A1 Jinju Peng
A1 Huiming Jiang
A1 Pingping Zhou
A1 Ting Hu
A1 Min Luo
A1 Yingtao Zhang
A1 Huanying Zheng
A1 Jianpeng Xiao
A1 Tao Liu
A1 Rongfei Che
A1 Hanri Zeng
A1 Zhonghua Zheng
A1 Yushi Huang
A1 Jianxiang Yu
A1 Lina Yi
A1 Jie Wu
A1 Jingdiao Chen
A1 Haojie Zhong
A1 Xiaoling Deng
A1 Min Kang
A1 Oliver G. Pybus
A1 Matthew Hall
A1 Katrina A. Lythgoe
A1 Yan Li
A1 Jun Yuan
A1 Jianfeng He
A1 Jing Lu
YR 2021
UL http://medrxiv.org/content/early/2021/07/23/2021.07.07.21260122.abstract
AB We report the first local transmission of the SARS-CoV-2 Delta variant in mainland China. All 167 infections could be traced back to the first index case. Daily sequential PCR testing of the quarantined subjects indicated that the viral loads of Delta infections, when they first become PCR+, were on average ∼1000 times greater compared to A/B lineage infections during initial epidemic wave in China in early 2020, suggesting potentially faster viral replication and greater infectiousness of Delta during early infection. We performed high-quality sequencing on samples from 126 individuals. Reliable epidemiological data meant that, for 111 transmission events, the donor and recipient cases were known. The estimated transmission bottleneck size was 1-3 virions with most minor intra-host single nucleotide variants (iSNVs) failing to transmit to the recipients. However, transmission heterogeneity of SARS-CoV-2 was also observed. The transmission of minor iSNVs resulted in at least 4 of the 30 substitutions identified in the outbreak, highlighting the contribution of intra-host variants to population level viral diversity during rapid spread. Disease control activities, such as the frequency of population testing, quarantine during pre-symptomatic infection, and level of virus genomic surveillance should be adjusted in order to account for the increasing prevalence of the Delta variant worldwide.Competing Interest StatementThe views expressed in this article are those of the authors and not necessarily those of the Guangdong Provincial Center for Diseases Control and Prevention, or the Guangdong Provincial Institute of Public Health.Funding Statement1.Science and Technology Planning Project of Guangdong (2018B020207006) 2.The Key Research and Development Program of Guangdong Province (2019B111103001) 3.Guangdong Workstation for Emerging infectious Disease Control and Prevention, Chinese Academy of Medical Sciences (2020-PT330-004)Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was approved by the institutional ethics committee of the Guangdong Provincial Center for Disease Control and Prevention (GDCDC). Written consent was obtained from patients or their guardian(s) when samples were collected. Patients were informed about the surveillance before providing written consent, and data directly related to disease control were collected and anonymized for analysis. For immunity evaluation, serum samples were collected from vaccinated volunteers in GDCDC with written consent.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll sequencing reads after primer trimming and mapped to the reference sequence (the sequences of the first index case, XG5137_GZ_2021/5/21) have been submitted to the National Genomics Data Center (https://bigd.big.ac.cn/) with submission number CRA004571. The generated consensus sequences were submitted with accession number GWHBDIM01000000-GWHBDNH01000000.